Table 2.
Level of inotropic support required in each patient (P not significant)
| Level | Plegisol, n | HTK, n |
|---|---|---|
| No support | 42 | 32 |
| 1a | 17 | 31 |
| 1b | 5 | 3 |
| 2 | 2 | 1 |
| 3 | 2 | 1 |
| Total | 68 | 68 |
HTK Custodiol histidine-tryptophan-ketoglutarate solution
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.